{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T16:10:05Z","timestamp":1746547805951,"version":"3.40.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.msard.2025.106338","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:53:50Z","timestamp":1741049630000},"page":"106338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Markedly elevated cerebrospinal fluid white blood cell count in multiple sclerosis: How high is too high?"],"prefix":"10.1016","volume":"96","author":[{"given":"Samar","family":"Ikram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-935X","authenticated-orcid":false,"given":"B. Mark","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2025.106338_bib0008","first-page":"27","article-title":"Atypical presentations of multiple sclerosis","author":"Anderson","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"4","key":"10.1016\/j.msard.2025.106338_bib0015","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1007\/s00415-022-11521-0","article-title":"CSF lymphocytic pleocytosis does not predict a less favourable long-term prognosis in MS","volume":"270","author":"Astbury","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106338_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.675307","article-title":"Cerebrospinal fluid findings in 541 patients with clinically isolated syndrome and multiple sclerosis: a monocentric study","author":"Berek","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2025.106338_bib0005","first-page":"290","article-title":"Misdiagnosis of multiple sclerosis: a retrospective analysis of clinical, imaging, and laboratory features","volume":"87","author":"Bourdette","year":"2016","journal-title":"Neurology"},{"year":"2021","series-title":"Cerebrospinal Fluid Analysis American Academy of Family Physicians","key":"10.1016\/j.msard.2025.106338_bib0016"},{"key":"10.1016\/j.msard.2025.106338_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00726","article-title":"The Cerebrospinal Fluid in Multiple Sclerosis","volume":"10","author":"Deisenhammer","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106338_bib0010","unstructured":"Diagnosis of MS: national Multiple Sclerosis Society; [Available from: https:\/\/nationalmssociety.org\/dx. 2024."},{"issue":"18","key":"10.1016\/j.msard.2025.106338_bib0012","article-title":"Cerebrospinal fluid pleocytosis in infectious and noninfectious central nervous system disease","volume":"96","author":"Egelund","year":"2017","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"10.1016\/j.msard.2025.106338_bib0001","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106338_bib0003","article-title":"The diagnosis of multiple sclerosis AMA","author":"Ganguly","year":"2006","journal-title":"J. Ethics"},{"issue":"955","key":"10.1016\/j.msard.2025.106338_bib0004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/pgmj.2004.029413","article-title":"Multiple sclerosis: diagnosis and the management of acute relapses","volume":"81","author":"Leary","year":"2005","journal-title":"Postgrad. Med. J."},{"issue":"4","key":"10.1016\/j.msard.2025.106338_bib0007","first-page":"687","article-title":"Cerebrospinal fluid analysis in multiple sclerosis","volume":"51","author":"Lindberg","year":"2005","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.msard.2025.106338_bib0014","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1212\/NXI.0000000000000584","article-title":"Does CSF pleocytosis have a predictive value for disease course in MS?","volume":"6","author":"Lotan","year":"2019","journal-title":"Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.msard.2025.106338_bib0009","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106338_bib0011","unstructured":"Red Flags: national Multiple Sclerosis Society [Available from: https:\/\/www.nationalmssociety.org\/for-professionals\/for-healthcare-professionals\/diagnosing-ms\/red-flags. 2024."},{"key":"10.1016\/j.msard.2025.106338_bib0006","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet North Am. Ed."},{"issue":"2","key":"10.1016\/j.msard.2025.106338_bib0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2025.106338_bib0017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2021","journal-title":"Lancet Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T15:42:15Z","timestamp":1746546135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":18,"alternative-id":["S2211034825000811"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106338","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markedly elevated cerebrospinal fluid white blood cell count in multiple sclerosis: How high is too high?","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106338"}}